The Human Papillomavirus Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Human Papillomavirus Testing Market: Drivers and Challenges
Growing burden of HPV incidence in women aged more than 30 years and prevalence of sexually transmitted diseases are major factors driving growth of global human papillomavirus testing market. According to World Health Organization (WHO) statistics, HPV related cervical cancer is the second most common cancer in women accounting for 13% of cancer deaths in the U.S. Moreover, as per Morbidity and Mortality Weekly Report by CDC, currently 79 Mn people in U.S. are infected with HPV with the addition of 14 Mn new HPV infections each year. Lack of clear guidelines for HPV testing and less adoption of new HPV testing methods by health practitioners are the factors limiting the growth of global human papillomavirus testing market.
Introduction of next generation HPV testing techniques for identification of type 16 and 18 HPV in samples is expected to boost the growth of human papillomavirus testing market over the forecast period. Based on technology, human papillomavirus tests are classified as DNA probe technology, and RNA probe technology. DNA probe technology segment is foreseen to lead the market owing to more number of approved products for HPV testing using DNA probes. The segment is expected to grow rapidly over the forecast period due to increasing adoption of the technique for cervical cancer screening by healthcare professionals.
Based on disease indication, cervical cancer segment is expected to contribute largest share in global human papillomavirus testing market due to availability of clear guidelines for the use of HPV test in cervical cancer screening. Based on end users, the global human papillomavirus testing market has been segmented into hospitals, clinics, Diagnostic Centers and Research Centers. Hospital end user segment is expected to contribute the maximum share among end users.
Human Papillomavirus Testing Market: Regional Overview
On the basis of regional presence, global human papillomavirus testing market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global human papillomavirus testing market for due to high prevalence HPV related diseases. According to WHO statistics, prevalence of HPV is high in developed countries such as U.S. and U.K.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11737
Human Papillomavirus Testing Market: Key Players
ome of the major players in global human papillomavirus testing market are Digene Corporation, Roche Molecular Systems, Inc, Hologic, Inc., Abbott Laboratories, Qiagen NV etc.
Browse Full Report summary and to request sample report and table of content@ http://www.persistencemarketresearch.com/market-research/human-papillomavirus-testing-market.asp
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353